ABBVIE INC. NEW YORK, Aug. 21, 2018 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against AbbVie Inc. ("AbbVie" or the "Company") (NYSE: ABBV). and certain of its officers, on behalf of shareholders who purchased or otherwise acquired AbbVie securities on May 30, 2018. Such investors are encouraged to join this case by visiting the firm's site: http://www.bgandg.com/abbv.
This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws.
The Complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements and/or failed to disclose the preliminary results of a previously announced modified Dutch auction to repurchase the Company's securities (the "Dutch Tender Offer"), stating that a total of 75.7 million shares were tendered at or below the purchase price of $105 per share. Then, at approximately 4:45 pm on May 30, 2018, AbbVie announced "updated preliminary results" of the Dutch Tender Offer, stating that a total of 74.0M shares of AbbVie's common stock had been tendered and not properly withdrawn at or below the lower purchase price of $103 per share. On this news, AbbVie's share price fell $4.07, or 3.95%, to close at $98.94 on May 31, 2018.
A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm's site: http://www.bgandg.com/abbv or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in AbbVie you have until September 24, 2018 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.
Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com
View original content with multimedia:http://www.prnewswire.com/news-releases/shareholder-alert---bronstein-gewirtz--grossman-llc-notifies-investors-of-class-action-against-abbvie-inc-abbv-and-lead-plaintiff-deadline--september-24-2018-300700019.html
SOURCE Bronstein, Gewirtz & Grossman, LLC
